The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease is characterized by a widespread functional disturbance of the human brain. Fibrillar amyloid proteins are deposited inside neurons as neurofibrillary tangles and extracellularly as amyloid plaque cores and in blood vessels. The major protein subunit (A4) of the amyloid fibril of tangles, plaques and blood vessel deposits is an insoluble, highly aggregating small polypeptide of relative molecular mass 4,500. The same polypeptide is also deposited in the brains of aged individuals with trisomy 21 (Down's syndrome). We have argued previously that the A4 protein is of neuronal origin and is the cleavage product of a larger precursor protein. To identify this precursor, we have now isolated and sequenced an apparently full-length complementary DNA clone coding for the A4 polypeptide. The predicted precursor consists of 695 residues and contains features characteristic of glycosylated cell-surface receptors. This sequence, together with the localization of its gene on chromosome 21, suggests that the cerebral amyloid deposited in Alzheimer's disease and aged Down's syndrome is caused by aberrant catabolism of a cell-surface receptor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Molecular imaging studies such as those using amyloid positron emission tomography (PET) have shown that Aβ deposition reaches a plateau before brain atrophy can be identified from structural magnetic resonance imaging (MRI) and cognitive symptoms [15, 19].”
From Clinical trials of new drugs for Alzheimer disease (2020) · cites this paper as [15]
In the citing paper
“All the mutant genes of hereditary, autosomal, and dominant familial AD, including amyloid precursor protein (APP), presenilin 1, and presenilin 2, encode the major proteins involved in amyloid metabolism [14–16].”
From Clinical trials of new drugs for Alzheimer disease (2020) · cites this paper as [15]
In the citing paper
“Amyloid  protein (A), the principal protein in the senile plaques of Alzheimer's disease (AD), is an ϳ4 kDa secreted polypeptide”
From Age-Dependent Changes in Brain, CSF, and Plasma Amyloid β Protein in the Tg2576 Transgenic Mouse Model of Alzheimer's Disease (2001) · cites this paper as Kang et al., 1987
In the citing paper
“APP isoforms are encoded by several alternatively spliced transcripts (Kang et al., 1987;K itaguchi et al., 1988;Ponte et al., 1988;Tanzi et al., 1988;Golde et al., 1990;Ko ¨nig et al., 1992).”
From Alzheimer Amyloid Protein Precursor in the Rat Hippocampus: Transport and Processing through the Perforant Path (1998) · cites this paper as Kang et al., 1987
In the citing paper
“APP, first identified by Kang et al. [18], is a type I transmembrane protein with a long luminal N-terminal domain and a small cytoplasmic C-terminal tail [18,19].”
From Advances in the cell biology of the trafficking and processing of amyloid precursor protein: impact of familial Alzheimer's disease mutations (2024) · cites this paper as [18]
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Detection of specific sequences among DNA fragments separated by gel electrophoresis
Southern, E. M. (1975) · Journal of Molecular Biology · doi:10.1016/s0022-2836(75)80083-0 · Cited by 32,249
Rigby, P. W. J., Dieckmann, M., Rhodes, C., & Berg, P. (1977) · Journal of Molecular Biology · doi:10.1016/0022-2836(77)90052-3 · Cited by 11,401
Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.
Thomas, P. S. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.9.5201 · Cited by 8,156
Aviv, H., & Leder, P. (1972) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.69.6.1408 · Cited by 6,751
Amyloid plaque core protein in Alzheimer disease and Down syndrome.
Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431
Self-citationLehrach, H., Diamond, D., Wozney, J. M., & Boedtker, H. (1977) · Biochemistry · doi:10.1021/bi00640a033 · Cited by 3,415
A gas-liquid solid phase peptide and protein sequenator.
Hewick, R. M., Hunkapiller, M. W., Hood, L. E., & Dreyer, W. J. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43377-7 · Cited by 2,218
Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein
Glenner, G. G., & Wong, C. W. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91209-9 · Cited by 1,693
A cellular gene encodes scrapie PrP 27-30 protein
Oesch, B., Westaway, D., Wälchli, M., McKinley, M. P., Kent, S. B. H., Aebersold, R., Barry, R. A., Tempst, P., Teplow, D. B., Hood, L. E., et al. (1985) · Cell · doi:10.1016/0092-8674(85)90333-2 · Cited by 1,513
Research works printed but not linked: 4
- Alzheimer, A. Allg. Z. Psychiat. 64, 146–148 (1907).
- Katzman, R. (ed.) Biological Aspects of Alzheimer's Disease (Banbury Report 15) (Cold Spring Harbor Laboratory, New York, 1983).
- Beyreuther, K. et al. in Discussions in Neuroscience Vol. 3 (eds Bignami, A., Bolis, L. & Gajdusek, D. C. 68–79 Fondation pour I'Étude du Système Nerveux, Geneva (1986).
- Goldgaber, D., Lerman, M. I., McBride, W. O., Sallow, V. & Gajdusek, D. C. Science (in the press).
Cited by
Items 301–400 of 1,071
Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein.
Cras, P., Kawai, M., Lowery, D., Gonzalez-DeWhitt, P., Greenberg, B., & Perry, G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.17.7552 · Cited by 319
Endogenous amyloid‐β is necessary for hippocampal synaptic plasticity and memory
Puzzo, D., Privitera, L., Fa', M., Staniszewski, A., Hashimoto, G., Aziz, F., Sakurai, M., Ribe, E. M., Troy, C. M., Mercken, M., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22313 · Cited by 278
Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer’s disease
Thal, D. R., Walter, J., Saido, T. C., & Fändrich, M. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1375-y · Cited by 319
Causative and susceptibility genes for Alzheimer’s disease: a review
Rocchi, A., Pellegrini, S., Siciliano, G., & Murri, L. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00067-4 · Cited by 316
Metabolism of the “Swedish” Amyloid Precursor Protein Variant in Neuro2a (N2a) Cells
Thinakaran, G., Teplow, D. B., Siman, R., Greenberg, B., & Sisodia, S. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.16.9390 · Cited by 317
Expression Analysis of BACE2 in Brain and Peripheral Tissues
Bennett, B. D., Babu-Khan, S., Loeloff, R., Louis, J.-C., Curran, E., Citron, M., & Vassar, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002688200 · Cited by 317
The complexity of Alzheimer’s disease: an evolving puzzle
Ferrari, C., & Sorbi, S. (2021) · Physiological Reviews · doi:10.1152/physrev.00015.2020 · Cited by 309
Johnstone, E. M., Chaney, M. O., Norris, F. H., Pascual, R., & Little, S. P. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90088-f · Cited by 316
Mao, P., & Reddy, P. H. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.08.005 · Cited by 313
“The A β peptide is a 38 – 43 amino acid in length and is generated by proteolytic processing of the APP, a cell-surface receptor via β -secretase ( β -amyloidcleavageenzyme,BACE1)and γ -secretasecomplexcontain- ing presenilins consequently [1,40,52 – 54].”
Prolines and Aamyloidogenicity in Fragments of the Alzheimer's Peptide .beta./A4
Wood, S. J., Wetzel, R., Martin, J. D., & Hurle, M. R. (1995) · Biochemistry · doi:10.1021/bi00003a003 · Cited by 312
Physiological Functions of APP Family Proteins
Muller, U. C., & Zheng, H. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006288 · Cited by 310
“Since the molecular cloning of APP, more than 20 years ago (Goldgaber et al. 1987; Kang et al. 1987; Tanzi et al. 1987), a large body of biochemical and genetic evidence has accumulated that identified Ab as a central trigger for AD pathogenesis.”
BackgroundChoo-Smith, L.-P., Garzon-Rodriguez, W., Glabe, C. G., & Surewicz, W. K. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.37.22987 · Cited by 312
The promoter of Alzheimer's disease amyloid A4 precursor gene.
Salbaum, J. M., Weidemann, A., Lemaire, H. G., Masters, C. L., & Beyreuther, K. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03136.x · Cited by 313
Self-citationvan Duinen, S. G., Castaño, E. M., Prelli, F., Bots, G. T., Luyendijk, W., & Frangione, B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.16.5991 · Cited by 205
Introduction and expression of the 400 kilobase precursor amyloid protein gene in transgenic mice
Lamb, B. T., Sisodia, S. S., Lawler, A. M., Slunt, H. H., Kitt, C. A., Kearns, W. G., Pearson, P. L., Price, D. L., & Gearhart, J. D. (1993) · Nature Genetics · doi:10.1038/ng0993-22 · Cited by 311
Metal complexing agents as therapies for Alzheimer’s disease
Bush, A. I. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00120-3 · Cited by 310
“[36] Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, et al.”
BackgroundAlexander, A. G., Marfil, V., & Li, C. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00279 · Cited by 310
“Like human APP (Kang et al., 1987), APL-1 contains a large extracellular region whose conserved E1 and E2 domains share 46 and 49% sequence similarity to human APP, respectively, a transmembrane domain, and a relatively small cytosolic domain, which shares 71% sequence similarity to human APP…”
BackgroundLewczuk, P., Riederer, P., O’Bryant, S. E., Verbeek, M. M., Dubois, B., Visser, P. J., Jellinger, K. A., Engelborghs, S., Ramirez, A., Parnetti, L., et al. (2018) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1375556 · Cited by 307
“In a variation of this methodology, one study used antibodies against the glutamate transporter (GLAST) to derive plasma EVs enriched for astrocytic origin and found elevations in enzymes involved in APP cleavage (BACE-1, c-secretase), Ab42 and ptau (Goetzl, Mustapic, et al. 2016).”
BackgroundInfluentialAmyloid-beta peptide and tau protein crosstalk in Alzheimer’s disease
Villegas, S., Roda, A., Serra-Mir, G., Montoliu-Gaya, L., & Tiessler, L. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.332127 · Cited by 306
“…Cascade Hypothesis 1666 Tau and Its Role in Neurodegeneration 1667 Amyloid-beta Peptide and Tau Protein Interplay: More Than Casual Partners 1669 Combined Therapies as a New Hope: Targeting Amyloid-beta and Tau 1670 NEURAL REGENERATION RESEARCH|Vol 17|No. 8|August 2022|1667 (Kang et al., 1987).”
BackgroundKwart, D., Gregg, A., Scheckel, C., Murphy, E. A., Paquet, D., Duffield, M., Fak, J., Olsen, O., Darnell, R. B., & Tessier-Lavigne, M. (2019) · Neuron · doi:10.1016/j.neuron.2019.07.010 · Cited by 304
Amyloid Structure: Conformational Diversity and Consequences
Toyama, B. H., & Weissman, J. S. (2011) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-090908-120656 · Cited by 304
“Aβ is a 39–42-residue peptide that is derived from the membrane protein amyloid-β precursor protein following proteolytic cleavage by β- and γ-secretases (89).”
Golde, T. E., Eckman, C. B., & Younkin, S. G. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00043-0 · Cited by 244
Putative function of ADAM9, ADAM10, and ADAM17 as APP -secretase
Asai, M., Hattori, C., Szabó, B., Sasagawa, N., Maruyama, K., Tanuma, S.-I., & Ishiura, S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02999-6 · Cited by 303
García-Ayllón, M.-S. (2011) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2011.00022 · Cited by 299
“…is the β-amyloid protein (Aβ), a small polypeptide generated by processing of a much larger transmembrane β-amyloid precursor protein (APP; Masters et al., 1985; Kang et al., 1987) through the successive action of proteolytic enzymes known as secretases (for a recent review see Zhang et al., 2011).”
BackgroundPlatelet Coagulation Factor XI a -Inhibitor, a Form of Alzheimer Amyloid Precursor Protein
Smith, R. P., Higuchi, D. A., & Broze, G. J. (1990) · Science · doi:10.1126/science.2111585 · Cited by 302
Dysregulation of Histone Acetylation in the APP/PS1 Mouse Model of Alzheimer's Disease
Francis, Y. I., Fà, M., Ashraf, H., Zhang, H., Staniszewski, A., Latchman, D. S., & Arancio, O. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1134 · Cited by 298
“Familial forms of AD [4,5] have been linked to mutations in the gene for amyloid-β protein precursor (A β PP) [4] and two other genes, presenilin 1 (PS1) and presenilin 2 (PS2) [6,7].”
Structure of Amyloid A4‐(1–40)‐Peptide of Alzheimer's Disease
Sticht, H., Bayer, P., Willbold, D., Dames, S., Hilbich, C., Beyreuther, K., Frank, R. W., & Rösch, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.293_1.x · Cited by 300
Self-citationLocalization of Amyloid β Protein Messenger RNA in Brains from Patients with Alzheimer's Disease
Bahmanyar, S., Higgins, G. A., Goldgaber, D., Lewis, D. A., Morrison, J. H., Wilson, M. C., Shankar, S. K., & Gajdusek, D. C. (1987) · Science · doi:10.1126/science.3299701 · Cited by 300
Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension.
McKinnon, S. J., Lehman, D. M., Kerrigan, L. A., Merges, C. A., Pease, M. E., Kerrigan, D., Ransom, N. L., Tahzib, N. G., Reitsamer, H. A., Levkovitch-Verbin, H., et al. (2002) · PubMed · Cited by 334
Protease Nexin-II(amyloid β-protein Precursor): a Platelet α-Granule Protein
Van Nostrand, W. E., Schmaier, A. H., Farrow, J. S., & Cunningham, D. D. (1990) · Science · doi:10.1126/science.2110384 · Cited by 296
Effect of aging on the blood-brain barrier
Mooradian, A. D. (1988) · Neurobiology of Aging · doi:10.1016/s0197-4580(88)80013-7 · Cited by 296
Molecular pathology of neurodegenerative diseases by cryo-EM of amyloids
Scheres, S. H. W., Ryskeldi-Falcon, B., & Goedert, M. (2023) · Nature · doi:10.1038/s41586-023-06437-2 · Cited by 288
Fiore, F., Zambrano, N., Minopoli, G., Donini, V., Duilio, A., & Russo, T. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.30853 · Cited by 294
The Profile of Soluble Amyloid β Protein in Cultured Cell Media
Wang, R., Sweeney, D., Gandy, S. E., & Sisodia, S. S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.31894 · Cited by 294
Signaling via NF-κB in the nervous system
Kaltschmidt, B., Widera, D., & Kaltschmidt, C. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2005.05.009 · Cited by 293
“[161] J.”
Axonal Transport and Alzheimer's Disease
Stokin, G. B., & Goldstein, L. S. B. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142637 · Cited by 293
Buxbaum, J. D., Thinakaran, G., Koliatsos, V., O’Callahan, J., Slunt, H. H., Price, D. L., & Sisodia, S. S. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-23-09629.1998 · Cited by 293
“APP isoforms are encoded by several alternatively spliced transcripts (Kang et al., 1987; Kitaguchi et al., 1988; Ponte et al., 1988; Tanzi et al., 1988; Golde et al., 1990; König et al., 1992).”
BackgroundAtwood, C. S., Obrenovich, M. E., Liu, T., Chan, H., Perry, G., Smith, M. A., & Martins, R. N. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00174-7 · Cited by 293
The amyloid cascade hypothesis: an updated critical review
Kepp, K. P., Robakis, N. K., Høilund-Carlsen, P. F., Sensi, S. L., & Vissel, B. (2023) · Brain · doi:10.1093/brain/awad159 · Cited by 284
Halverson, K., Fraser, P. E., Kirschner, D. A., & Lansbury, P. T. (1990) · Biochemistry · doi:10.1021/bi00463a003 · Cited by 292
Rogers, J. T., Leiter, L. M., McPhee, J., Cahill, C. M., Zhan, S.-S., Potter, H., & Nilsson, L. N. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6421 · Cited by 290
Lipids as Modulators of Proteolytic Activity of BACE
Kalvodova, L., Kahya, N., Schwille, P., Ehehalt, R., Verkade, P., Drechsel, D., & Simons, K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504484200 · Cited by 289
Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases
Gan, L., & Johnson, J. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.12.011 · Cited by 288
Complement activation in amyloid plaques in Alzheimer’s dementia
Eikelenboom, P., Hack, C. E., Rozemuller, J. M., & Stam, F. C. (1988) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02890024 · Cited by 288
“ceptor (Kang et al. 1987).”
Divide and Die: Cell Cycle Events as Triggers of Nerve Cell Death
Herrup, K., Neve, R., Ackerman, S. L., & Copani, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3347-04.2004 · Cited by 287
“This idea was first proposed on the basis of its predicted amino acid sequence, which suggested that APP was a type 1 intrinsic membrane protein consistent with the structure of a “cell surface receptor” (Kang et al., 1987).”
BackgroundVDAC1, mitochondrial dysfunction, and Alzheimer’s disease
Shoshan-Barmatz, V., Nahon-Crystal, E., Shteinfer-Kuzmine, A., & Gupta, R. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.010 · Cited by 286
Haga, S., Akai, K., & Ishii, T. (1989) · Acta Neuropathologica · doi:10.1007/bf00687883 · Cited by 286
“fl-protein have been characterized [14, 21, 33, 36] and”
Nascent astrocyte particles differ from lipoproteins in CSF
LaDu, M. J., Gilligan, S. M., Lukens, J. R., Cabana, V. G., Reardon, C. A., Van Eldik, L. J., & Holtzman, D. M. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70052070.x · Cited by 285
Microtubule-Associated Protein Tau
Yen, S.-H., Nacharaju, P., Ko, L.-W., Kenessey, A., & Liu, W.-K. (1998) · Handbook of the Aging Brain · doi:10.1016/b978-012734610-6/50012-9 · Cited by 282
Sisodia, S., Koo, E., Hoffman, P., Perry, G., & Price, D. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-07-03136.1993 · Cited by 284
Xia, W., Zhang, J., Kholodenko, D., Citron, M., Podlisny, M. B., Teplow, D. B., Haass, C., Seubert, P., Koo, E. H., & Selkoe, D. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.7977 · Cited by 284
Bosco, D., Fava, A., Plastino, M., Montalcini, T., & Pujia, A. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2011.01318.x · Cited by 283
Copper levels are increased in the cerebral cortex and liver of APP and APLP2 knockout mice
White, A. R., Reyes, R., Mercer, J. F. B., Camakaris, J., Zheng, H., Bush, A. I., Multhaup, G., Beyreuther, K., Masters, C. L., & Cappai, R. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01861-2 · Cited by 282
Self-citationStructural and kinetic features of amyloid β-protein fibrillogenesis: Review
Teplow, D. B. (1998) · Amyloid · doi:10.3109/13506129808995290 · Cited by 283
Alzheimer's disease: a cell biological perspective
Kosik, K. (1992) · Science · doi:10.1126/science.1589757 · Cited by 283
Yamaguchi, H., Hirai, S., Morimatsu, M., Shoji, M., & Ihara, Y. (1988) · Acta Neuropathologica · doi:10.1007/bf00689591 · Cited by 283
“dues of which were almost identical to those of fl protein [9].”
MethodResultThe role of Aβ42 in Alzheimer's disease
Younkin, S. G. (1998) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(98)80035-1 · Cited by 282
Haass, C., Hung, A., & Selkoe, D. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-12-03783.1991 · Cited by 282
“For PCR-mediated amplification of human OAPP mRNAs, we used the following oligonucleotide primers: KPI-R, which corresponds to the reverse sequence of OAPP ( Kang et al., 1987 ) between base pairs (bp) 921 and 901 (GGC-GGATCCAGGTGTCTTCGAGATACTTGT), and KPI-F between bp 834 and 853 (GGCGAATTCACCACAGAGTCTGTGGAAG) (Podli…”
BackgroundMethodInfluentialOltersdorf, T., Ward, P. J., Henriksson, T., Beattie, E. C., Neve, R., Lieberburg, I., & Fritz, L. C. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39590-0 · Cited by 282
Rice, H. C., de Malmazet, D., Schreurs, A., Frere, S., Van Molle, I., Volkov, A. N., Creemers, E., Vertkin, I., Nys, J., Ranaivoson, F. M., et al. (2019) · Science · doi:10.1126/science.aao4827 · Cited by 281
Human amyloid precursor protein ameliorates behavioral deficit of flies deleted for appl gene
Luo, L., Tully, T., & White, K. (1992) · Neuron · doi:10.1016/0896-6273(92)90024-8 · Cited by 280
“The major component of extracellular amyloid plaques in brains of Alzheimer disease patients, the B-amyloid protein, is derived from the B-amyloid precursor protein (APP) (Kang et al., 1987; Coldgaber et al., 1987; Robakis et al., 1987; Tanzi et al., 1987; for a recent review, see Selkoe, 1991).”
BackgroundMethodEhlers, M. R. W., & Riordan, J. F. (1991) · Biochemistry · doi:10.1021/bi00106a001 · Cited by 281
Inhibition of NF-κB potentiates amyloid β-mediated neuronal apoptosis
Kaltschmidt, B., Uherek, M., Wellmann, H., Volk, B., & Kaltschmidt, C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9409 · Cited by 279
Molecular genetics of Alzheimer’s disease
St George-Hyslop, P. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00301-7 · Cited by 265
Dawkins, E., & Small, D. H. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12675 · Cited by 279
“Ab was identified by Glenner and Wong (1984) and the first complete cDNA sequence encoding human APP was cloned in 1987 (Kang et al. 1987).”
BackgroundInfluentialSolvent effects on self-assembly of beta-amyloid peptide
Shen, C. L., & Murphy, R. M. (1995) · Biophysical Journal · doi:10.1016/s0006-3495(95)79940-4 · Cited by 277
Zhang, Z., Song, M., Liu, X., Su Kang, S., Duong, D. M., Seyfried, N. T., Cao, X., Cheng, L., Sun, Y. E., Ping Yu, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms9762 · Cited by 277
“(1) AEP might translocate from the endolysosome into the cytoplasmic space, where it cleaves tau; (2) intracellular AEP cuts SET, leading to PP2A inhibition and consequent tau hyperphosphorylation; (3) intracellular AEP can be fused with the endocytosed APP; (4) activated AEP might be secreted extracellularly, where i…”
BackgroundBeal, M. F. (2004) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000041772.74810.92 · Cited by 277
Protein phosphorylation inhibits production of Alzheimer amyloid beta/A4 peptide.
Buxbaum, J. D., Koo, E. H., & Greengard, P. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9195 · Cited by 277
Broeckhoven, C. V., Genthe, A. M., Vandenberghe, A., Horsthemke, B., Backhovens, H., Raeymaekers, P., Hul, W. V., Wehnert, A., Gheuens, J., Cras, P., et al. (1987) · Nature · doi:10.1038/329153a0 · Cited by 274
Self-citationA Furin-like Convertase Mediates Propeptide Cleavage of BACE, the Alzheimer's β-Secretase
Bennett, B. D., Denis, P., Haniu, M., Teplow, D. B., Kahn, S., Louis, J.-C., Citron, M., & Vassar, R. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005339200 · Cited by 273
Aβ42 is More Rigid than Aβ40 at the C Terminus: Implications for Aβ Aggregation and Toxicity
Yan, Y., & Wang, C. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.09.046 · Cited by 273
Guilloreau, L., Combalbert, S., Sournia‐Saquet, A., Mazarguil, H., & Faller, P. (2007) · ChemBioChem · doi:10.1002/cbic.200700111 · Cited by 270
Exploring the Etiology of Alzheimer Disease Using Molecular Genetics
Lendon, C. L. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340059034 · Cited by 273
Hepatocyte Growth Factor Activator Inhibitor, a Novel Kunitz-type Serine Protease Inhibitor
Shimomura, T., Denda, K., Kitamura, A., Kawaguchi, T., Kito, M., Kondo, J., Kagaya, S., Qin, L., Takata, H., Miyazawa, K., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6370 · Cited by 272
Hutter-Paier, B., Huttunen, H. J., Puglielli, L., Eckman, C. B., Kim, D. Y., Hofmeister, A., Moir, R. D., Domnitz, S. B., Frosch, M. P., Windisch, M., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.08.043 · Cited by 229
Tagliavini, F., Giaccone, G., Frangione, B., & Bugiani, O. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90080-8 · Cited by 271
Chen, X.-H., Siman, R., Iwata, A., Meaney, D. F., Trojanowski, J. Q., & Smith, D. H. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63303-2 · Cited by 271
Melo, J. B., Agostinho, P., & Oliveira, C. R. (2003) · Neuroscience Research · doi:10.1016/s0168-0102(02)00201-8 · Cited by 271
“The major constituent of senile plaques, occurring in Alzheimer’s disease (AD), is amyloid b-peptide (Ab), a 40 /42 amino acid peptide, which is a cleaved form of the amyloid precursor protein (APP) (Kang et al., 1987; Tanzi et al., 1988).”
BackgroundSynaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice
Mucke, L., Masliah, E., Johnson, W. B., Ruppe, M. D., Alford, M., Rockenstein, E. M., Forss-Petter, S., Pietropaolo, M., Mallory, M., & Abraham, C. R. (1994) · Brain Research · doi:10.1016/0006-8993(94)90767-6 · Cited by 271
Spatial resolution of fodrin proteolysis in postischemic brain.
Saido, T. C., Yokota, M., Nagao, S., Yamaura, I., Tani, E., Tsuchiya, T., Suzuki, K., & Kawashima, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74593-1 · Cited by 270
Chan, W. Y., Liu, Q. R., Borjigin, J., Busch, H., Rennert, O. M., Tease, L. A., & Chan, P. K. (1989) · Biochemistry · doi:10.1021/bi00429a017 · Cited by 270
A constitutive nucleolar protein identified as a member of the nucleoplasmin family.
Schmidt-Zachmann, M. S., Hügle-Dörr, B., & Franke, W. W. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02447.x · Cited by 270
Tanzi, R. E., George-Hyslop, P. H. S., Haines, J. L., Polinsky, R. J., Nee, L., Foncin, J.-F., Neve, R. L., McClatchey, A. I., Conneally, P. M., & Gusella, J. F. (1987) · Nature · doi:10.1038/329156a0 · Cited by 269
Linkage and mutational analysis of familial Alzheimer disease kindreds for the APP gene region.
Kamino, K., Orr, H. T., Payami, H., Wijsman, E. M., Alonso, M. E., Pulst, S. M., Anderson, L., O'dahl, S., Nemens, E. J., & White, J. A. (1992) · PubMed Central · Cited by 302
Torroja, L., Packard, M., Gorczyca, M., White, K., & Budnik, V. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-18-07793.1999 · Cited by 268
“APP is synthesized as a transmembrane glycoprotein composed of extracellular, transmembrane, and cytoplasmic domains (Kang et al., 1987; Luo et al., 1990; Wasco et al., 1993).”
BackgroundMethodInfluentialApplication of Metabolomics in Alzheimer’s Disease
Wilkins, J. M., & Trushina, E. (2018) · Frontiers in Neurology · doi:10.3389/fneur.2017.00719 · Cited by 268
The biological pathways of Alzheimer disease: a review
Calabrò, M., Department of Biomedical and Dental Sciences and Morphofunctional Imaging, U. O. M., Rinaldi, C., Santoro, G., & Crisafulli, C. (2021) · AIMS Neuroscience · doi:10.3934/neuroscience.2021005 · Cited by 265
Surfactant properties of Alzheimer's A beta peptides and the mechanism of amyloid aggregation.
Soreghan, B., Kosmoski, J., & Glabe, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61939-3 · Cited by 267
The role of metallobiology and amyloid-β peptides in Alzheimer's disease
Roberts, B. R., Ryan, T. M., Bush, A. I., Masters, C. L., & Duce, J. A. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07500.x · Cited by 266
Self-citationThe ubiquitin‐proteasome system in Alzheimer's disease
Oddo, S. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00276.x · Cited by 264
“364 (APP), which is encoded by a gene located on chromosome 21 [14].”
BackgroundLocalization of Alzheimer βA4 amyloid precursor protein at central and peripheral synaptic sites
Schubert, W., Prior, R., Weidemann, A., Dircksen, H., Multhaup, G., Masters, C. L., & Beyreuther, K. (1991) · Brain Research · doi:10.1016/0006-8993(91)91532-6 · Cited by 265
Self-citationVandenabeele, P., & Fiers, W. (1991) · Immunology Today · doi:10.1016/0167-5699(91)90032-o · Cited by 264
Generation of amyloid β protein from its precursor is sequence specific
Citron, M., Teplow, D. B., & Selkoe, D. J. (1995) · Neuron · doi:10.1016/0896-6273(95)90323-2 · Cited by 263
Butterfield, D. A., Hardas, S. S., & Lange, M. L. B. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1375 · Cited by 262
Guo, J.-P., Arai, T., Miklossy, J., & McGeer, P. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509386103 · Cited by 261
Ando, K., Iijima, K.-I., Elliott, J. I., Kirino, Y., & Suzuki, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104059200 · Cited by 261
The C‐Terminus of the β Protein is Critical in Amyloidogenesisa
JARRETT, J. T., BERGER, E. P., & LANSBURY, P. T. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb23043.x · Cited by 260
A Mathematical Model of the Kinetics of β-Amyloid Fibril Growth from the Denatured State
Pallitto, M. M., & Murphy, R. M. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)75831-6 · Cited by 259
“Ab is a 39- to 43-residue proteolytic product of a membrane-associated precursor protein, APP, containing sequences from both extracellular and transmembrane regions of the parent protein (Kang et al., 1987; Masters et al., 1985).”
BackgroundGenetic Neurodegenerative Diseases: The Human Illness and Transgenic Models
Price, D. L., Sisodia, S. S., & Borchelt, D. R. (1998) · Science · doi:10.1126/science.282.5391.1079 · Cited by 259
Metadata
- Authors
- Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B.
- Affiliations
- University of Cologne (DE)
- Venue
- Nature
- Published
- 1987-02
- Volume
- 325
- Issue
- 6106
- Pages
- 733-736
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2081881251
- Cited by
- 4,619
- References
- 26
- Citations by year
- 2026: 38 · 2025: 58 · 2024: 63 · 2023: 71 · 2022: 54 · 2021: 79 · 2020: 82 · 2019: 76 · 2018: 76 · 2017: 98 · 2016: 111 · 2015: 90 · 2014: 97 · 2013: 119 · 2012: 126
- FWCI
- 164.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, amyloid precursor protein, cell surface receptors, Down syndrome, amyloid plaques, neurofibrillary tangles, chromosome 21, cDNA cloning, protein sequences
- MeSH terms
- Alzheimer Disease, Amyloid, Base Sequence, Brain, Brain Chemistry, Chromosomes, Human, Pair 21, DNA, Down Syndrome, Fetus, Humans, Neurofibrils, Nucleic Acid Hybridization, Protein Precursors, Protein Processing, Post-Translational, RNA, Messenger, Amyloid beta-Peptides, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.